DPH greatly appreciates the partnership of health care providers and organizations to administer the COVID-19 vaccine to their patient population and their surrounding community members.
It is now easier to enroll and provide COVID-19 vaccinations –
View the flyer to learn more.
Detailed information regarding enrollment processes for joining the California COVID-19 Vaccination Program can be found at: https://eziz.org/covid/enrollment/. The DPH Vaccination Partner Checklist has information and resources for providers offering COVID-19 vaccine.
This toolkit contains COVID-19 vaccine resources for patients (including fact sheets for parents and teens and activity sheets for children) along with provider resources (including sample letters) to support you when discussing and promoting COVID-19 vaccination to your patients.
Providers cannot charge any out-of-pocket cost for COVID-19 vaccine. The vaccine must be made available at no cost to all individuals to ensure equitable access. Denying anyone vaccination or reducing appointments based on the person’s insurance status, charging for an office visit or other fee (if COVID-19 vaccination is the sole medical service provided), requiring additional medical services to receive COVID-19 vaccination, or seeking any additional reimbursement, including through balance billing from the vaccine recipient, is prohibited.
The loss of the HRSA COVID-19 Uninsured Program funding may prove a challenge to serving your neediest community members. Public Health is working hard to advocate with the federal and state government on your behalf. In the meantime, here are some considerations and resources to assist providers:
See New and Noteworthy for new webinars
Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.
Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment
CDC/CISAvax (Clinical Immunization Safety Assessment Project) - Consults about COVID-19 vaccine safety. Healthcare providers can request a consultation from CISA COVIDvax for a complex COVID-19 vaccine safety question that is (1) about an individual patient residing in the United States or vaccine safety issue and (2) not readily addressed by CDC or Advisory Committee on Immunization Practices (ACIP) guidelines. CISA has vaccine safety subject matter experts in multiple specialties (e.g. ID, allergy/immunology, neurology, OB/GYN, pediatrics, geriatrics)
Medical professionals interested in supporting the COVID-19 response:
Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. Document functionality may be reduced if you are using an earlier version (4.x or less). Get the latest version of Adobe Acrobat.
Public Health has made reasonable efforts to provide accurate translation. However, no computerized translation is perfect and is not intended to replace traditional translation methods. If questions arise concerning the accuracy of the information, please refer to the English edition of the website, which is the official version.
